Latest Lupus News

Joy Keys Chats with the Faces of Stroke AmbassadorsPhiladelphia, PA, May 26, 2012 --(PR.com)-- Faces of Stroke Ambassadors Date: May 26th, 2012 Time: 11:00 a.m. – 11:30 a.m. ET Call In Number: 646-929-0368. Url: http://www.blogtalkradio.com/joykeys/2012/05/26/joy-keys-chats-with-the-faces-of-stroke-ambassadors Lenice Hogan: Hogan is a survivor of not one stroke, but three, all at young ages. She survived hemorrhagic strokes at the ages...

Deals Of The Week Jump Starts The Summer Reading List

High on the New York Times List of Bestsellers (in the hardcover advice & miscellaneous category) this spring has been the book “Innovation: Create Far From Home, Win Everywhere.”It’s by two well-known Dartmouth business school professors,...

3 Teams Named Winners of AppsforHealth 2012 ChallengeMohawk College brings together Ontario college and university students to find solutions for healthcare technology issues. (PRWEB) May 25, 2012 With 100 industry professionals from over 20 attending organizations, and more than 60 students from colleges and universities from across Ontario, Mohawk College’s second annual AppsforHealth event was a much anticipated success. The two-day event prov...

11 Scientists Funded to Move Arthritis Research ForwardEleven cutting-edge scientists researching arthritis have been awarded grants totaling $810,000 by the Arthritis National Research Foundation. Moving arthritis research forward with new, innovative ideas. Long Beach, CA (PRWEB) May 25, 2012 Eleven scientists researching arthritis were recently awarded grants totaling $810,000 by the Arthritis National Research Foundation. With 50 million America...

Partnership aims to develop diagnostic for lupus flaresXDx is collaborating with LabCorp to create and market a biomarker-based assay for lupus flares. -More-

One-Third of Arthritis Patients Also Experience Anxiety, DepressionAllsup highlights importance of working closely with physicians for treatment and when applying for Social Security disability benefits Belleville, IL (PRWEB) May 24, 2012 A new national study finds that one-third of people with arthritis also experience anxiety or depression. This combination of physical and mental impairments points to the complexity of chronic illness and the importance of wor...

Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare ConferenceANAHEIM, Calif., May 24, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Jefferies 2012 Global Healthcare Conference in New York on June 6, 2012 at 5:00 a.m. PT / 8:00 a.m. ET. A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm. The replay w...

XDx, LabCorp sign new collaboration, license agreementXDx, a molecular diagnostics company, has signed a collaboration and license agreement with Laboratory Corporation of America Holdings (LabCorp) to develop Lupus Flare Predictor test.

LabCorp, XDx partner to develop and commercialize SLE flare predictor testXDx, Inc. announced today that it has entered into a collaboration and license agreement with Laboratory Corporation of America Holdings (LabCorp)whereby each party will collaborate in marker discovery, and LabCorp will develop and commercialize a di...

LabCorp, XDx in deal for lupus flare predictive testLaboratory Corp. of America Holdings (NYSE:LH) and XDx Inc. (Brisbane, Calif.) partnered to discover biomarkers to predict flares of systemic lupus erythematosus (SLE) and develop a predictive test based on the markers. The partners said the deal com...

NYSE/NASDAQ SNAPSHOT: Movado, Hormel, Facebook, Dell, Google and moreFine watch maker Movado Group (NYSE:MOV) revealed Wednesday its fiscal first quarter 2013 preliminary results, and increased its guidance for the full fiscal year. Shares of Movado rallied more than nine percent Wednesday afternoon, to $28.28. Movado...

GSK amends offer conditions in response to Human Genome Sciences poison pill GlaxoSmithKline (LON:GSK) has amended the terms of its offer for Human Genome Sciences (NASDAQ:HGSI) after the latter launched a poison pill defence last week. Pharmaceutical giant GSK originally offered US$13 per share for HGS, which i...

ImmuPharma sets sights on Lupuzor advancement and cancer programme in 2012The main aim for drug discovery specialist ImmuPharma (LON:IMM) in 2012 are to advance its Lupuzor drug and its cancer treatment programme. So said chief executive officer Dimitri Dimitriou at the firm's AGM earlier today. He told shareholders 2011...

XDx and LabCorp Enter Into Collaboration and License Agreement to Develop Lupus Flare Predictor TestXDx, Inc. announced today that it has entered into a collaboration and license agreement with Laboratory Corporation of America® Holdings (LabCorp) (NYSE: LH) whereby each party will collaborate in marker discovery, and LabCorp will develop and commercialize a diagnostic test to predict flares of systemic lupus erythematosus (SLE). The agreement combines...

XDx, LabCorp to Develop Lupus Flare Predictor Test

Celiac Awareness Month Twitter Chat Hosted by Saturday Mornings with Joy KeysPhiladelphia, PA, May 23, 2012 --(PR.com)-- Celiac Awareness Twitter Chat Date: Wednesday May 23rd, 2012 Time: 7:00 p.m. - 7:45 p.m. ET Hashtag: #smjkceliac Twitter hooks to follow: @joykeys @celiacawareness @celiacalliance @CherylHarrisRD @cureceliac Special Guest: Cheryl McEvoy, Online Content Manager, National Foundation for Celiac Awareness @celiacawareness Special Guest: Andrea Levario...

S.L.E. Lupus Foundation Gathers City Leaders to Advance Professional Education and Training in NYCNEW YORK, May 23, 2012 (GLOBE NEWSWIRE) -- More than 50 New York City leaders addressed critical issues affecting the lupus community at the Gaining Ground: The Latest on Lupus in New York – a briefing hosted by the S.L.E. Lupus Foundation. Presentations outlined the challenges of identifying and treating lupus, recent research advances and critical steps for improving care by rolling out the n...

Human Genome Sciences devises poison pill to ward off GSK bidHuman Genome Sciences (NASDAQ:HGSI) has come up with a ‘poison pill’ defence against the US$2.6 billion hostile bid from Britain’s GlaxoSmithKline (LON:GSK).GSK has tabled a US$13 a share offer that has been rebuffed by the American...

Human Genome Sciences Board of Directors Unanimously Determines GlaxoSmithKline Unsolicited Tender Offer is Inadequate and Not in the Best Interests of StockholdersHuman Genome Sciences, Inc. (Nasdaq: HGSI) today announced that its Board of Directors, after careful review and consideration with the assistance of the Company’s management and financial and legal advisors, has unanimously determined that the unsolicited tender offer from GlaxoSmithKline (“GSK”) to acquire all outstanding common shares of HGS for $...

Questcor Pharmaceuticals Expands Repurchase ProgramANAHEIM, Calif., May 16, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that its Board of Directors has increased the Company's common share repurchase program authorization by an additional 5 million shares. Since the beginning of 2008, the Company has returned $236 million to shareholders through the repurchase of approximately 19.2 million comm...

Bel Marra Health Supports A Recent Study That Says Eye Color Can Be A Determining Factor For VitiligoBel Marra Health, well known for offering high-quality, specially formulated vitamins and nutritional supplements, supports a recent study that says eye color can be a determining factor for vitiligo. Toronto, ON (PRWEB) May 16, 2012 Bel Marra Health, well known for offering high-quality, specially formulated vitamins and nutritional supplements, supports a recent study that says eye color can be...

LPGA Pro, Kristy McPherson, Films Arthritis Awareness VideoIn honor of arthritis awareness month, LPGA Professional, Kristy McPherson, has filmed a juvenile arthritis awareness video about her story and the Arthritis National Research Foundation. Long Beach, CA (PRWEB) May 15, 2012 May is Arthritis Awareness Month. LPGA Professional, Kristy McPherson took time from her LPGA Tour schedule to film an arthritis awareness testimonial, focusing on her story a...

Change in Lupus Manifests with Mild Symptoms (CME/CE)RALEIGH, N.C. (MedPage Today) -- Patients who had cutaneous lupus erythematosus and progressed to systemic disease had more moderate and severe symptoms than patients who had systemic lupus erythematosus at the outset.

Pharmas provide $23.1M for early stage researchA group of six pharmas will provide L14.4 million ($23.1 million) to fund a research consortium at the University of Dundee for an additional four years. The Division of Signal Transduction Therapy (DSTT) consortium, which was founded in 1998, is stu...

Bristol-Myers Squibb to Present New Data on ORENCIA® (abatacept) at the European League Against Rheumatism (EULAR) 2012 CongressBristol-Myers Squibb Company (NYSE: BMY) today announced that the company will present 18 abstracts on ORENCIA® (abatacept) at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology in Berlin, June 6-9. Among the data being presented will be results from the AMPLE study, a head-to-head phase 3 clinical trial compari...

0 1 2 3 4 ›»

buy Lupus market research data and corporate reports now Advertisement